Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.

Revenue
+3.95%
EPS
+34.8%
Free cash flow
−7.09%
Total debt
+15.6%

Quarter to September 2026, against a year earlier

85.40 2.84 −3.22%
Market cap
$9.4B
P/E
22.8×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

Henry Schein, Inc. (HSIC) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Henry Schein, Inc. (HSIC) trades at a price to free cash flow of 17.0×. Over the past ten years it has ranged from 9.7× (April 2020) to 29.8× (February 2024); the current reading is higher than 34% of that period. That is below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 15.9× 27.14%
FY2024 12.5× (55.17%)
FY2023 28.0× 30.62%
FY2022 21.4× 24.35%
FY2021 17.2× (0.64%)
FY2020 17.3× 1.50%
FY2019 17.1× 12.59%
FY2018 15.2× (15.75%)
FY2017 18.0× 5.35%
FY2016 17.1× (9.64%)

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 16.7× 0.37%
Jun 2026 16.7× (12.52%)
Mar 2026 19.0× 19.46%
Dec 2025 15.9× (19.50%)
43 more quarters

Against its own ten years

Low 9.7× High 29.8×
Ten-year median 17.8×
Current reading's percentile 34

Price to free cash flow against peers

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on HSIC